Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1983 Oct;24(4):486–493. doi: 10.1128/aac.24.4.486

Agar disk elution method for susceptibility testing of Mycobacterium marinum and Mycobacterium fortuitum complex to sulfonamides and antibiotics.

M S Stone, R J Wallace Jr, J M Swenson, C Thornsberry, L A Christensen
PMCID: PMC185360  PMID: 6651277

Abstract

An agar disk elution method using round well plates, supplemented Mueller-Hinton agar, and commercial drug disks is described for susceptibility testing of Mycobacterium marinum and the rapidly growing mycobacteria to antibiotics and sulfonamides. By this method, 14 of 14 strains of M. marinum were susceptible to rifampin, doxycycline, minocycline, and trimethoprim-sulfamethoxazole. Identical results were obtained with Middlebrook 7H10 agar and drugs prepared from standard powders. With 58 isolates of Mycobacterium fortuitum and Mycobacterium chelonei, this method had a 92% correlation with broth minimal inhibitory concentration determinations for cefoxitin and greater than 98% for doxycycline, kanamycin, amikacin, and the sulfonamides. Sixty-nine percent of isolates of M. chelonei susceptible to amikacin on supplemented Mueller-Hinton agar were resistant on 7H10 agar, and 15 of 16 M. chelonei isolates susceptible to erythromycin in broth were resistant by disk elution when an endpoint of no growth was used with either agar. The agar disk elution method offers a practical method for testing of most antibacterial agents against these mycobacterial species.

Full text

PDF
486

Images in this article

489Image
on p.489

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BAUER A. W., SHERRIS J. C. THE DETERMINATION OF SULFONAMIDE SUSCEPTIBILITY OF BACTERIA. Chemotherapy. 1964;9(1):1–19. doi: 10.1159/000220337. [DOI] [PubMed] [Google Scholar]
  2. Black M. M., Eykyn S. J. The successful treatment of tropical fish tank granuloma (Mycobacterium marinum) with co-trimoxazole. Br J Dermatol. 1977 Dec;97(6):689–692. doi: 10.1111/j.1365-2133.1977.tb14279.x. [DOI] [PubMed] [Google Scholar]
  3. Casal M., Rodríguez F. In vitro susceptibility of mycobacterium fortuitum and mycobacterium chelonei to cefoxitin. Tubercle. 1982 Jun;63(2):125–127. doi: 10.1016/s0041-3879(82)80049-4. [DOI] [PubMed] [Google Scholar]
  4. Cynamon M. H., Patapow A. In vitro susceptibility of Mycobacterium fortuitum to cefoxitin. Antimicrob Agents Chemother. 1981 Jan;19(1):205–207. doi: 10.1128/aac.19.1.205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dalovisio J. R., Pankey G. A. In vitro susceptiiblity of Mycobacterium fortuitum and Mycobacterium chelonei to amikacin. J Infect Dis. 1978 Mar;137(3):318–321. doi: 10.1093/infdis/137.3.318. [DOI] [PubMed] [Google Scholar]
  6. Dalovisio J. R., Pankey G. A., Wallace R. J., Jones D. B. Clinical usefulness of amikacin and doxycycline in the treatment of infection due to Mycobacterium fortuitum and Mycobacterium chelonei. Rev Infect Dis. 1981 Sep-Oct;3(5):1068–1074. doi: 10.1093/clinids/3.5.1068. [DOI] [PubMed] [Google Scholar]
  7. Fass R. J., Barnishan J. Minimal inhibitory concentrations of 34 antimicrobial agents for control strains Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853. Antimicrob Agents Chemother. 1979 Nov;16(5):622–624. doi: 10.1128/aac.16.5.622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Griffith M. E., Matajack M. L., Bissett M. L., Wood R. M. Cooperative field test of drug-impregnated discs for susceptibility testing of mycobacteria. Am Rev Respir Dis. 1971 Mar;103(3):423–426. doi: 10.1164/arrd.1971.103.3.423. [DOI] [PubMed] [Google Scholar]
  9. Irwin R. S., Pratter M. R., Corwin R. W., Farrugia R., Teplitz C. Pulmonary infection with Mycobacterium chelonei: successful treatment with one drug based on disk diffusion susceptibility data. J Infect Dis. 1982 May;145(5):772–772. doi: 10.1093/infdis/145.2.772. [DOI] [PubMed] [Google Scholar]
  10. Kim R. Letter: Tetracycline therapy for atypical mycobacterial granuloma. Arch Dermatol. 1974 Aug;110(2):299–299. doi: 10.1001/archderm.1974.01630080087041. [DOI] [PubMed] [Google Scholar]
  11. Kirk J., Kaminski G. W. Mycobacterium marinum infection. Australas J Dermatol. 1976 Dec;17(3):111–116. doi: 10.1111/j.1440-0960.1976.tb00802.x. [DOI] [PubMed] [Google Scholar]
  12. Kuritsky J. N., Bullen M. G., Broome C. V., Silcox V. A., Good R. C., Wallace R. J., Jr Sternal wound infections and endocarditis due to organisms of the Mycobacterium fortuitum complex. Ann Intern Med. 1983 Jun;98(6):938–939. doi: 10.7326/0003-4819-98-6-938. [DOI] [PubMed] [Google Scholar]
  13. Loria P. R. Minocycline hydrochloride treatment for atypical acid-fast infection. Arch Dermatol. 1976 Apr;112(4):517–519. [PubMed] [Google Scholar]
  14. Ryan K. J., Needham G. M., Dunsmoor C. L., Sherris J. C. Stability of antibiotics and chemotherapeutics in agar plates. Appl Microbiol. 1970 Sep;20(3):447–451. doi: 10.1128/am.20.3.447-451.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Sanders W. J., Wolinsky E. In vitro susceptibility of Mycobacterium marinum to eight antimicrobial agents. Antimicrob Agents Chemother. 1980 Oct;18(4):529–531. doi: 10.1128/aac.18.4.529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Silcox V. A., Good R. C., Floyd M. M. Identification of clinically significant Mycobacterium fortuitum complex isolates. J Clin Microbiol. 1981 Dec;14(6):686–691. doi: 10.1128/jcm.14.6.686-691.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Swenson J. M., Thornsberry C., Silcox V. A. Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution. Antimicrob Agents Chemother. 1982 Aug;22(2):186–192. doi: 10.1128/aac.22.2.186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Torres J. R., Sands M., Sanders C. V. In vitro sensitivity of Mycobacterium marinum to minocycline and doxycycline. Tubercle. 1978 Sep;59(3):193–195. doi: 10.1016/0041-3879(78)90026-0. [DOI] [PubMed] [Google Scholar]
  19. Wallace R. J., Jr, Dalovisio J. R., Pankey G. A. Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents. Antimicrob Agents Chemother. 1979 Nov;16(5):611–614. doi: 10.1128/aac.16.5.611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Wallace R. J., Jr, Jones D. B., Wiss K. Sulfonamide activity against Mycobacterium fortuitum and Mycobacterium chelonei. Rev Infect Dis. 1981 Sep-Oct;3(5):898–904. doi: 10.1093/clinids/3.5.898. [DOI] [PubMed] [Google Scholar]
  21. Wallace R. J., Jr, Wiss K., Bushby M. B., Hollowell D. C. In vitro activity of trimethoprim and sulfamethoxazole against the nontuberculous mycobacteria. Rev Infect Dis. 1982 Mar-Apr;4(2):326–331. doi: 10.1093/clinids/4.2.326. [DOI] [PubMed] [Google Scholar]
  22. Wallace R. J., Jr, Wiss K. Susceptibility of Mycobacterium marinum to tetracyclines and aminoglycosides. Antimicrob Agents Chemother. 1981 Nov;20(5):610–612. doi: 10.1128/aac.20.5.610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Wayne L. G., Krasnow I. Preparation of tuberculosis susceptibility testing mediums by means of impregnated disks. Am J Clin Pathol. 1966 Jun;45(6):769–771. doi: 10.1093/ajcp/45.6_ts.769. [DOI] [PubMed] [Google Scholar]
  24. Welch D. F., Kelly M. T. Antimicrobial susceptibility testing of Mycobacterium fortuitum complex. Antimicrob Agents Chemother. 1979 Jun;15(6):754–757. doi: 10.1128/aac.15.6.754. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Wolinsky E., Gomez F., Zimpfer F. Sporotrichoid Mycobacterium marinum infection treated with rifampin-ethambutol. Am Rev Respir Dis. 1972 Jun;105(6):964–967. doi: 10.1164/arrd.1972.105.6.964. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES